Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
41.47
+0.08 (0.19%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $4.06 billion as of July 22, 2024. Its market cap has increased by 522.67% in one year.
Market Cap
4.06B
Enterprise Value
3.63B
1-Year Change
522.67%
Ranking
Category
Stock Price
$41.47
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $4.06B, an increase of 413.24%. That is a compound annual growth rate of 53.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.62B | 343.93% |
| Dec 29, 2023 | 816.30M | 35.10% |
| Dec 30, 2022 | 604.20M | -1.39% |
| Dec 31, 2021 | 612.70M | -35.80% |
| Dec 31, 2020 | 954.30M | 20.66% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inspire Medical Systems | 4.27B |
| Integer Holdings | 4.23B |
| Alkermes | 4.20B |
| Crinetics Pharmaceuticals | 4.15B |
| Immunovant | 4.09B |
| Axsome Therapeutics | 4.03B |
| ImmunityBio | 4.00B |
| Ultragenyx Pharmaceutical | 3.85B |